Pharmacokinetics of tranexamic acid during cardiopulmonary bypass

被引:208
作者
Dowd, NP
Karski, JM
Cheng, DC
Carroll, JA
Lin, YG
James, RL
Butterworth, J
机构
[1] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Div Cardiac Anesthesia & Intens Care, Toronto, ON M5G 2C4, Canada
[2] Wake Forest Univ, Sch Med, Dept Anesthesiol, Winston Salem, NC 27109 USA
关键词
D O I
10.1097/00000542-200208000-00016
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Tranexamic acid (TA) reduces blood loss and blood transfusion during heart surgery with cardiopulmonary bypass (CPB). TA dosing has been empiric because only limited pharmacokinetic studies have been reported, and CPB effects have not been characterized. We hypothesized that many of the published TA dosing techniques would prove, with pharmacokinetic modeling and simulation, to yield unstable TA concentrations. Methods: Thirty adult patients undergoing elective coronary artery bypass grafting, valve surgery, or repair of atrial septal defect received after induction of anesthesia: TA 50 mg/kg (n = 11), TA 100 mg/kg (n = 10), or TA 10 mg/kg (n = 10) over 15 min, with 1 mg . kg(-1) . hr(-1) maintenance infusion for 10 h. TA was measured in plasma using high performance liquid chromatography. Pharmacokinetic modeling was accomplished using a mixed effects technique. Models of increasing complexity were compared using Schwarz-Bayesian Criterion (SBC). Results: Tranexamic acid concentrations rapidly fell in all three groups. Data were well fit to a 2-compartment model, and adjustments for CPB were supported by SBC. Assuming a body weight of 80 kg, our model estimates V-1 = 10.3 1 before CPB and 11.9 1 during and after CPB; V-2 = 8.5 1 before CPB and 9.8 1 during and after CPB; Cl-1 = 0.15 Us before CPB, 0.11 Us during CPB, and 0.17 Us after CPB; and Cl-2 = 0.18 Us before CPB and 0.21 Us during and after CPB. Based on simulation of previous studies of TA efficacy, we estimate that a 30-min loading dose of 12.5 mg/kg with a maintenance infusion of 6.5 mg . kg(-1) . hr(-1) and 1 mg/kg added to the pump prime will maintain TA concentration greater than 334 mum, and a higher dose based on 30 mg/kg loading dose plus 16 mg . kg(-1) . h(-1) continuous infusion and 2 mg/kg added to the pump prime would maintain TA concentrations greater than 800 mum. Conclusions: Tranexamic acid pharmacokinetics are influenced by CPB. Our TA pharmacokinetic model does not provide support for the wide range of TA dosing techniques that have been reported. Variation in TA efficacy from study to study and confusion about the optimal duration of TA treatment may be the result of dosing techniques that do not maintain stable, therapeutic TA concentrations.
引用
收藏
页码:390 / 399
页数:10
相关论文
共 35 条
  • [11] Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery
    Dryden, PJ
    OConnor, P
    Jamieson, WRE
    Reid, I
    Ansley, D
    Sadeghi, H
    Burr, LH
    Munro, AI
    Merrick, PM
    [J]. CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1997, 44 (09): : 934 - 941
  • [12] Fiechtner BK, 2001, ANESTH ANALG, V92, P1131
  • [13] PHARMACOKINETICS OF COMPUTER-CONTROLLED ALFENTANIL ADMINISTRATION IN CHILDREN UNDERGOING CARDIAC-SURGERY
    FISET, P
    MATHERS, L
    ENGSTROM, R
    FITZGERALD, D
    BRAND, SC
    HSU, F
    SHAFER, SL
    [J]. ANESTHESIOLOGY, 1995, 83 (05) : 944 - 955
  • [14] HEDLUND P O, 1969, Scandinavian Journal of Urology and Nephrology, V3, P177, DOI 10.3109/00365596909135401
  • [15] THE DOSE-RESPONSE RELATIONSHIP OF TRANEXAMIC ACID
    HORROW, JC
    VANRIPER, DF
    STRONG, MD
    GRUNEWALD, KE
    PARMET, JL
    [J]. ANESTHESIOLOGY, 1995, 82 (02) : 383 - 392
  • [16] Karski J M, 1993, J Cardiothorac Vasc Anesth, V7, P431
  • [17] PREVENTION OF BLEEDING AFTER CARDIOPULMONARY BYPASS WITH HIGH-DOSE TRANEXAMIC ACID - DOUBLE-BLIND, RANDOMIZED CLINICAL-TRIAL
    KARSKI, JM
    TEASDALE, SJ
    NORMAN, P
    CARROLL, J
    VANKESSEL, K
    WONG, P
    GLYNN, MFX
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (03) : 835 - 842
  • [18] The effect of three different doses of tranexamic acid on blood loss after cardiac surgery with mild systemic hypothermia (32°C)
    Karski, JM
    Dowd, NP
    Joiner, R
    Carroll, J
    Peniston, C
    Bailey, K
    Glynn, MFX
    Teasdale, SJ
    Cheng, DCH
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1998, 12 (06) : 642 - 646
  • [19] The effectiveness of low dose tranexamic acid in primary cardiac surgery
    Lambert, W
    Brisebois, FJ
    Wharton, TJ
    Carrier, RC
    Boyle, D
    Rowe, BH
    [J]. CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1998, 45 (06): : 571 - 574
  • [20] Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion as the outcome
    Laupacis, A
    Fergusson, D
    [J]. ANESTHESIA AND ANALGESIA, 1997, 85 (06) : 1258 - 1267